Variable | Values (%) |
---|---|
Total No. of Patients (N) | 112 |
Age, Mean (SD) | 61.6 (10.4) |
Age Group, N (%) | |
< 60 | 42 (37.50) |
60–69 | 47 (41.96) |
> =70 | 23 (20.54) |
Sex, N (%) | |
Male | 87 (77.68) |
Female | 25 (22.32) |
BMI (Mean ± SD) | 27.8 (5.9) |
Smoking, N (%) | |
Never | 32 (28.57) |
Former/Current | 80 (71.43) |
Diabetes, N (%) | |
Yes | 29 (25.89) |
No | 83 (74.11) |
CAD, N (%) | |
Yes | 34 (30.36) |
No | 78 (69.64) |
COPD, N (%) | |
Yes | 17 (15.18) |
No | 95 (84.82) |
PET-CT, N (%) | |
Yes | 112 (100) |
EUS, N (%) | |
Yes | 94 (83.93) |
No | 18 (16.07) |
Histology, N (%) | |
Adenocarcinoma | 105 (93.75) |
Squamous cell carcinoma | 6 (5.36) |
Neuroendocrine | 1 (0.89) |
Neoadjuvant CRT, N (%) | |
Yes | 112 (100) |
Clinical Stage, N (%) | |
I | 3 (2.68) |
II | 12 (10.71) |
III | 97 (86.61) |